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The past few months have seen several impor-
tant events pointing out to the place and impor-
tance of chronic lung diseases in the world. In July
2011, several days after Poland assumed the pre-
sidency of the European Union (EU), a Member
States Health Ministers’ conference took place,
during which the Polish Minister of Health, Ewa
Kopacz, said that treatment of chronic lung dise-
ases is one of the health priorities of the Polish
presidency.
On 19–20 September 2011 the United Nations
(UN) General Assembly convened a High-Level
Meeting on Non-Communicable Diseases (NCD),
which, in addition to chronic respiratory diseases,
also include cardiovascular diseases, cancer, and
diabetes. NCDs have recently become major cau-
ses of death worldwide. A total of 35 million pe-
ople died from NCDs in 2008, which accounted for
63% of all deaths that year. People below 60 years
of age comprised one fourth of the deaths (9 mil-
lion). According to the forecasts presented by the
authors of the UN report, NCDs will cost the lives
of 52 million people in 2030. The experts explain
this disturbing tendency by factors that are main-
ly associated with unhealthy lifestyle (smoking,
poor diet leading to obesity, limited physical acti-
vity, and alcohol abuse). The Polish delegation
headed by the Polish deputy health minister, Dr
Adam Fronczak, led, on behalf of the EU Member
States, the negotiations on the final shape of the
political declaration. The delegation was also in-
volved, from the very beginning, in the work of the
UN General Assembly and made a very important
contribution to its success in the form of the una-
nimous adoption by all the UN members of a dec-
laration pointing out the problems associated with
the epidemic of chronic NCDs, including chronic
respiratory diseases such as asthma and chronic
obstructive pulmonary disease (COPD).
In September 2011, at its annual meeting, the
European Respiratory Society (ERS) presented The
European Respiratory Roadmap [1], a document
setting out the position of the ERS and the propo-
sed actions for the prevention, clinical care, heal-
thcare organisation, and research with respect to
respiratory diseases. This is the second document,
after The White Book published in 2003, to present
the health situation in the European Union and
point out the important role of lung diseases.
The prevalence of lung diseases is one of the
highest in the world. Approximately 500 million
people worldwide are affected by asthma and
COPD, and approximately 9.27 million people are
suffering from tuberculosis. According to the
World Health Organisation, approximately 4 mil-
lion people annually die from chronic respiratory
diseases, and this number is expected to increase
by 30% within the next 10 years [2]. Over the past
30 years there has been a disturbing tendency to-
wards an increased mortality due to COPD (the
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quiring palliative management and provides deta-
iled tips on the treatment of troublesome manife-
stations that cause suffering and anxiety to the pa-
tients. This pioneering document emphasizes the
role of social, psychological, and spiritual support
and communication with the patients. Thanks to
these recommendations, attention has been drawn
to the problems encountered both by the physi-
cians and other healthcare professionals and by the
patients and their families strayling with progres-
sive intractable lung diseases. The document de-
scribes an integrated care model that is necessa-
ry to provide appropriate multidisciplinary me-
dical and psychological care and organisation of
palliative care with the involvement of volunte-
ers. This model has proved successful in the pi-
lot study conducted in the territory of the Pome-
ranian Province, Poland. An observational stu-
dy is being planned with the involvement of four
sites in Pomerania to assess the effectiveness of
this form of care.
Hopefully, thanks to this document, the mes-
sage about the necessity to provide palliative care
not only to cancer patients but also to patients suf-
fering from chronic lung diseases leading to dysp-
noea, pain, exhaustion syndrome, and respiratory
failure will reach a wider audience and talks with
policymakers will start soon to receive appropria-
te funding for implementation of this system.
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mortality rate has doubled in this period), while
mortality due to cardiovascular diseases, stroke, and
even cancer has been constantly decreasing [3].
In Poland, with the exception of asthma [4],
detailed epidemiological data on chronic NCDs are
lacking. Based on isolated reports concerning li-
mited populations, it is estimated that approxima-
tely 2 million people are affected by COPD, 1.7
million by asthma, and 22 thousand by lung can-
cer. In 2009, 24 thousand patients died from lung
cancer, 8.7 thousand from COPD, and approxima-
tely 500 from asthma [5]. Approximately 20% of
COPD patients (400 thousand), 5% of asthma pa-
tients (75 thousand), and nearly all lung cancer
patients (81%) are suffering from severe or very
severe forms of these diseases. Such a high degree
of severity requires provision of comprehensive
medical care to these patients, which is necessary
to achieve symptomatic improvement, increase the
quality of life and reduce the number of hospitali-
sations, and — in the terminal period of life — to
relieve physical and psychological suffering and
to reduce disability (hospice care).
The Polish Respiratory Society recommenda-
tions on palliative care in chronic lung diseases pu-
blished in this issue of Polish Pneumonology and
Allergology [6] are devoted to this problem. It is a
document developed by the experts of the Polish
Respiratory Society, the Polish Society of Palliati-
ve Medicine, and other experts with experience in
the organisation of the palliative care of cancer pa-
tients. This document is an excellent contribution
to the on-going discussion on the role of lung di-
seases in the shameful statistics of the new pande-
mic of NCDs and provides ready-to-use solutions
on the management of patients with advanced lung
diseases. The recommendations present funda-
mental epidemiological data on the wide spectrum
of chronic respiratory diseases in Poland, descri-
be the clinical picture and prognosis of individual
disease entities, and emphasize the significance of
co-morbidities. A large portion of the recommen-
dations is devoted to the signs and symptoms re-
